Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden · Delayed Price · Currency is SEK 454.80
-5.20 (-1.13%)
Sep 4, 2026, 5:29 PM CET
STO:SOBI Market Cap
STO:SOBI has a market cap or net worth of 157.95 billion as of September 4, 2026. Its market cap has increased by 62.88% in one year.
Market Cap
157.95B
Enterprise Value
174.46B
Revenue
30.62B
Ranking
n/a
PE Ratio
114.97
Stock Price
454.80
ChartMarket Cap Chart
Since September 15, 2006, STO:SOBI's market cap has increased from 4.83B to 157.95B, an increase of 3,171.29%. That is a compound annual growth rate of 19.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 157.95B | 37.70% |
| Dec 30, 2025 | 114.70B | 4.06% |
| Dec 30, 2024 | 110.22B | 20.19% |
| Dec 29, 2023 | 91.70B | 41.80% |
| Dec 30, 2022 | 64.67B | 16.86% |
| Dec 30, 2021 | 55.34B | 12.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.47B |
| Cereno Scientific AB | 1.36B |
| Nanexa AB | 1.14B |
| Dicot Pharma AB | 793.64M |
| EQL Pharma AB | 747.10M |
| Cinclus Pharma Holding AB | 630.12M |
| Moberg Pharma AB | 540.69M |
| Orexo AB | 525.92M |